Effect of Agonist GLP1 on Adipose Tissue in Patients Undergoing Bariatric Surgery
Recruiting
N/A
Interventional Study
Obesity
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 40 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Nice · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Normalizing weight gain and preventing the redistribution of body fat is a major health issue, and could help prevent the onset of various symptoms of metabolic syndrome. Above all, it is important to understand the mechanisms by which these different treatments affect adipose tissue. To this end, the investigators will first study the impact of GLP-1 analogues on adipose tissue. The main objectiv…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patient over 18 years of age.
* Patient able to read and understand the information/consent leaflet.
* Patient with BMI \> 35 with at least one comorbidity. Or BMI \> 40
* Indication for digestive surgery validated in a multidisciplinary consultation meeting and prior agreemen…
Contacts